Skip to main content
Erschienen in: Orphanet Journal of Rare Diseases 1/2017

Open Access 01.12.2017 | Research

Impacts of caring for a child with the CDKL5 disorder on parental wellbeing and family quality of life

verfasst von: Yuka Mori, Jenny Downs, Kingsley Wong, Barbara Anderson, Amy Epstein, Helen Leonard

Erschienen in: Orphanet Journal of Rare Diseases | Ausgabe 1/2017

Abstract

Background

Although research in this area remains sparse, raising a child with some genetic disorders has been shown to adversely impact maternal health and family quality of life. The aim of this study was to investigate such impacts in families with a child with the CDKL5 disorder, a newly recognised genetic disorder causing severe neurodevelopmental impairments and refractory epilepsy.

Methods

Data were sourced from the International CDKL5 Disorder Database to which 192 families with a child with a pathogenic CDKL5 mutation had provided data by January 2016. The Short Form 12 Health Survey Version 2, yielding a Physical Component Summary and a Mental Component Summary score, was used to measure primary caregiver’s wellbeing. The Beach Center Family Quality of Life Scale was used to measure family quality of life. Linear regression analyses were used to investigate relationships between child and family factors and the various subscale scores.

Results

The median (range) age of the primary caregivers was 37.0 (24.6–63.7) years and of the children was 5.2 (0.2–34.1) years. The mean (SD) physical and mental component scores were 53.7 (8.6) and 41.9 (11.6), respectively. In mothers aged 25–54 years the mean mental but not the physical component score was lower than population norms. After covariate adjustment, caregivers with a tube-fed child had lower mean physical but higher mean mental component scores than those whose child fed orally (coefficient = −4.80 and 6.79; p = 0.009 and 0.012, respectively). Child sleep disturbances and financial hardship were negatively associated with the mental component score. The mean (SD) Beach Center Family Quality of Life score was 4.06 (0.66) and those who had used respite services had lower scores than those who had not across the subscales.

Conclusions

Emotional wellbeing was considerably impaired in this caregiver population, and was particularly associated with increased severity of child sleep problems and family financial difficulties. Family quality of life was generally rated lowest in those using respite care extensively, suggesting that these families may be more burdened by daily caregiving.
Abkürzungen
aa
Amino acid
BCFQOL
Beach center family quality of life
CDKL5
Cyclin-dependent kinase-like 5
ICDD
International CDKL5 disorder database
IFCR
International foundation for CDKL5 research
MCS
Mental component summary
PCS
Physical component summary
RTT
Rett syndrome
SDSC
Sleep disturbance scale for children
SF-12v2
Short form 12 health survey version 2

Background

The CDKL5 disorder is a recently identified genetic disorder caused by mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene [1]. These mutations were originally identified in children or adults who had been clinically diagnosed with epileptic encephalopathy [2] or the early-onset seizure variant of Rett syndrome (RTT) [3]. However, there has been recent evidence demonstrating some differences in clinical features when compared with typical RTT [46]. Epilepsy is almost universal and generally occurs in early infancy with a median age of six weeks ranging from one week to 1.5 years [4, 7] and thus symptoms of this disorder appear very early in life. Sleep difficulties appear to be more common in the CDKL5 disorder than in RTT [4, 6]. Genotype-phenotype relationships have been difficult to study because of the paucity of recurrent mutations and the generally small case series. Our recent study (n = 127) which examined early development in this disorder categorised mutation types into four groups according to the effect on protein function and found that compared with those with no functional protein, those with a truncating mutation after amino acid (aa) 781 were more likely to acquire motor and communication skills [8].
Growing evidence suggests that raising a child with a disability greatly impacts the welfare of the primary caregiver, particularly, the mother. Although there is an increasing number of studies examining maternal health [9, 10], research specifically targeting families caring for a child with a genetic disorder remains relatively scarce. While impaired mental health has been reported for those with a child with Down syndrome [11] and RTT [12, 13], and increased stress for those with a child with Prader-Willi syndrome [14], there are no data on the health of parents caring for a child with the CDKL5 disorder.
The concept of family quality of life for those with a child with a developmental disability has developed along with understanding of the crucial role that family plays in raising a child with a disability [15]. Identifying specific challenges for the family is critical to providing an inclusive and multidisciplinary healthcare strategy [16]. The burden of care may impact more greatly on families with a child who have more severe neurodevelopmental impairments accompanied with complex comorbidities and this is typical in many rare disorders. Often, the child’s diagnosis and access to syndrome-specific family support can be considerably delayed, adversely affecting parental wellbeing [17] and possibly also family quality of life.
The aim of this study is to examine primary caregivers’ wellbeing and family quality of life among families with a child living with the CDKL5 disorder, and determine the relationships with a range of factors from child’s characteristics through family circumstances to availability of public resources. This study is the first investigation into family life for those raising a child with the CDKL5 disorder.

Methods

Data collection

Prior to 2012 the international Rett syndrome database, InterRett, set up in 2002, and mainly collecting data using electronic data submission [4, 18], also included cases with the CDKL5 disorder. In 2012 the International CDKL5 Disorder Database (ICDD) was established by recontacting those InterRett families in whose child a CDKL5 gene mutation had been identified, and by recruiting new cases in collaboration with the International Foundation for CDKL5 Research (IFCR). Following registration on the IFCR webpage, an ICDD staff member contacts the family, explains the study and provides instructions on how they can complete the questionnaire and provide their genetic test results. The questionnaire comprises two primary components and an epilepsy diary. The first part includes sections that provide a comprehensive picture of the child’s clinical condition from birth to present: perinatal details; primary concerns and diagnosis; developmental milestones; regression; current functional ability, including gross motor, communication and feeding; past and current seizure frequency and medication; sleep difficulties; emotional and social development; stereotypic hand movements; gastrointestinal symptoms; skeletal and muscular health; other comorbidities; hospitalisations; drug treatments; stage of puberty; current body measurements; equipment and intervention use; day care and educational supports; and utilisation of respite care and financial aids. Questions were also asked about the specific forms of respite care used, where formal respite included services provided by public or private organisations and informal respite referred to any service offered by other family members, friends and neighbours. The second part includes sections regarding family demographics, family wellbeing using the Beach Center Family Quality of Life (BCFQOL) Scale, and parental wellbeing using the Short Form 12 Health Survey Version 2 (SF-12v2).
For the current study, data were collected between September 2012 and January 2016. Of those with a confirmed pathogenic mutation, 192 of 209 provided questionnaire data. One hundred and fifty-eight families (82.2% of 192) were included in the parental health analysis excluding 34 of those with three or more missing items. Of those, 141 (89.2%) questionnaires were completed by the biological mother, 15 (9.5%) by the biological father, and one (0.6%) each by a foster mother and a grandparent. In the family quality of life analysis, 149 families with fewer than three missing items (77.6% of 192) were included. The questionnaires were filled out by 131 (87.9%) biological mothers, 16 (10.7%) biological fathers, one foster mother (0.7%) and one grandparent (0.7%).

Measurements

Child’s mutation group

There was considerable variability in mutations in the CDKL5 gene with 149 unique and only 18 recurrent mutations. Hence, every mutation was categorised into one of five groups according to the subsequent protein function: No functional protein; Missense/in-frame mutations within kinase domain; Truncations between aa172 and aa781; Truncations after aa781; and mutations that could not be grouped [8].

Child’s functional abilities

For those aged 1.5 years or over, abilities to sit on the floor for ten seconds and to walk ten steps were categorised as needing no assistance, needing some support or unable. Also in those aged 1.5 years or over, ability to communicate was categorised as using no or simple communication methods (eg, body language and facial expressions), complex gestures and vocalisation (eg, selects or rejects a photo of object, points at an object or returns an unwanted item) or using sign or spoken language (eg, single words and sentences). Children or adults who were totally dependent on enteral feeding were excluded from analyses relating to dietary concerns.

Child’s sleep

The Sleep Disturbance Scale for Children (SDSC) has been validated in children with disability as well as healthy children [19]. It contains 26 items rated on a five-point Likert scale [19]. Four items were not included in the questionnaire as they were not appropriate to this population (e.g. the child sleep walks). The average score of the remaining 22 items was calculated with a possible range of one to five among those with no more than two missing items. Higher scores indicate poorer quality of the child’s sleep and data were stratified into quartile groups.

Child’s hospitalisations

A hospital admission rate was calculated by dividing the total number of reported hospitalisations by the child’s age. Data were then stratified into quartile groups.

Primary caregiver wellbeing

The SF-12v2 is a valid and reliable instrument of assessing self-reported health and wellbeing [20]. It comprises twelve items that form two scales, the Physical Component Summary (PCS) and Mental Component Summary (MCS), and eight subscales, including Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional and Mental Health [20]. The score is calculated based on a norm-referencing method using the US general norms collected in 1998 with a mean score of 50 and standard deviation (SD) of 10. Higher scores indicate better health status. Overall, 149 individuals answered all items, and seven and two families had one and two missing items, respectively. For each of eight subscales, a mean value among those without any missing data was applied to best estimate when the subscale score calculation resulted in failure due to the missing items.

Family quality of life

The BCFQOL Scale assesses family quality of life, specifically, for those raising children with a disability [21, 22]. The instrument, originally developed in the US, has been used in other countries including Australia and Spain [21]. It comprises 25 items with five subscales: Family interaction; Parenting; Emotional wellbeing; Physical/Material wellbeing; and Disability-related support [22]. The average of total item scores is obtained for each factor, with a possible value of one to five (three and four are rated when a family are neither satisfied or dissatisfied and satisfied with an item, respectively). Higher scores indicate better family quality of life. In total, 130 families responded to every item, and 16 and three individuals had one and two missing items, respectively.

Analysis

The PCS and MCS scores of the SF-12v2, and five factor scores of the BCFQOL Scale were the dependent variables. Univariate linear regression analyses were performed to investigate their crude relationships with the independent variables including family aspects such as parent’s age and employment status, child’s characteristics such as current functional ability and SDSC scores, and use of social supports such as respite care services. Multivariate linear regression analyses aimed to examine effects of the child’s clinical symptoms and socio-environmental factors on the SF-12v2 and BCFQOL scores and included adjustment for potential confounders, including socio-demographic factors, family composition and child’s age. These variables comprised parent’s age, highest qualification and work status, as well as child’s age, birth order, number of siblings, and country of birth. Age was a continuous variable and qualification and country of birth were binary variables (i.e. university degree or lower, North America or others, respectively) in the models. Multivariate linear regression models for subscales of the BCFQOL Scale included the PCS and MCS as continuous variables as well as all the abovementioned adjustors because the SF-12v2 and BCFQOL scale were scored by the same family member. Differences in mean PCS and MCS scores between 141 biological mothers and the US female norms were assessed using t-tests. The statistical package Stata 14 (StataCorp LP, College Station, TX) was used for all the analyses.

Results

Table 1 shows the child and family characteristics if the child had a confirmed pathogenic mutation in the CDKL5 gene, regardless of whether they fulfilled inclusion criteria for the analyses. At ascertainment, biological parents ranged in age from 24.6 to 63.7 years with a median of 38.5 years. Approximately 60% (59.4%) had university degrees, whereas nearly half (47.5%) were full-time homemakers or unemployed. The child’s median age was 5.2 years, varying from 0.2 to 34.1 years, and the majority (85.4%) were females. Over half of the children (52.4%) were born in the US, followed by the United Kingdom (UK) and Australia (both 7.3%). More than three quarters (77.2%) had siblings and nearly half (46.3%) were the first child for the parents. Each of the following mutation groups (no functional protein, missense or in-frame mutations within kinase domain, and truncations from aa172 to aa781) accounted for between a quarter and a third of the cases.
Table 1
Family demographics and the child’s characteristics in the database (n=192)
Family factors
Parental age (n=160) mean (SD), years
38.2 (7.0)
n (%)
 Under 30 years
14 (8.8)
 30 to 40 years
84 (52.5)
 40 years or over
62 (38.8)
Parental qualification (n=160), n (%)
 11 or 12 years of school
34 (21.3)
 TAFE/technical certificate
31 (19.4)
 University degree
95 (59.4)
Parental work status (n=160), n (%)
 Full-time homemaker/unemployment
76 (47.5)
 Part-time employment
39 (24.4)
 Full-time employment
45 (28.1)
Number of siblings (n=162), n (%)
 0
37 (22.8)
 1
67 (41.4)
 2 or more
58 (35.8)
Birth order (n=162), n (%)
 The first child
75 (46.3)
 Laterborn
87 (53.7)
Child factors
Child’s age (n=192) mean (SD), years
7.1 (6.1)
n (%)
 
 Under 1.5 years
30 (15.6)
 1.5 to 7 years
86 (44.8)
 7 to 13 years
48 (25.0)
 13 years
28 (14.6)
Child’s gender (n=192), n (%)
 Female
164 (85.4)
 Male
28 (14.6)
Child’s country of birth (n=191), n (%)
 North America
105 (55.0)
 The United Kingdom
14 (7.3)
 Australia and New Zealand
16 (8.4)
 Western Europe
38 (19.9)
 Others
18 (9.4)
Mutation group (n=192), n (%)
 No functional protein
55 (28.7)
 Missense/In-frame mutations within kinase domain
48 (25.0)
 Truncations from aa172 to aa781
58 (30.2)
 Truncations after aa781
16 (8.3)
 Mutations not grouped
15 (7.8)
Feeding pattern (n=171), n (%)
 Oral intake only
128 (74.9)
 Combination use#2
16 (9.4)
 Enteral nutrition only#3
27 (15.8)
Dietary concerns (n=139)#4, n (%)
 None
66 (47.5)
 Occasional
47 (33.8)
 Frequent/constant
26 (18.7)
Floor sitting (n=144)#5, n (%)
 No assistance
89 (61.8)
 Some assistance
14 (9.7)
 Mximal assistance/unable
41 (28.5)
Taking 10 steps forward (n=141)#5, n (%)
 No assistance
30 (21.3)
 Some assistance
20 (14.2)
 Mximal assistance/unable
91 (64.5)
Eye contact (n=158), n (%)
 No
85 (53.8)
 Yes
73 (46.2)
Communication (n=143)#5, n (%)
 No/Simple communication
53 (37.1)
 Complex gestures/vocalisation
62 (43.4)
 Sign/Spoken language
28 (19.6)
Seizure frequency (n=160), n (%)
 Absent
14 (8.8)
 Yearly/Monthly
16 (10.0)
 Weekly
27 (16.9)
 1 to 5 times per day
74 (46.3)
 At least 5 times per day
29 (18.1)
Sleep difficulties (average SDSC score) (n=155), n (%)
 1 to 1.50 (1st quartile)
38 (24.5)
 1.50 to 1.81 (2nd quartile)
39 (25.2)
 1.81 to 2.17 (3rd quartile)
40 (25.8)
 2.17 to 5 (4th quartile)
38 (24.5)
Hospitalisation rate (n=156), per 1 person-year, n (%)
 0 to 0.38 (1st quartile)
39 (25.0)
 0.38 to 0.86 (2nd quartile)
39 (25.0)
 0.86 to 2.14 (3rd quartile)
39 (25.0)
 2.14 to 13.70 (4th quartile)
39 (25.0)
Socio-environmental factors
Respite care (n=153), n(%)
 None
41 (26.8)
 Formal respite care only
21 (13.7)
 Informal respite care only
41 (26.8)
Both formal and informal respite care
50 (32.7)
Financial difficulty (n=147), n (%)
 No
83 (56.5)
 Yes
64 (43.5)
#1 North America includes the United States (100) and Canada (5). Australia and New Zealand contains Australia (14) and New Zealand (2). Western Europe includes Germany (12), France (7), the Netherlands (6), Ireland (3), Spain (2), Italy (2), Belgium (1), Denmark (1), Finland (1), Norway (1), Sweden (1) and Luxemburg (1). Others comprises Brazil (3), India (2), Russia (2), Hungary (2), Bulgaria (1), Poland (1), Slovenia (1), Israel (1), China (1), Singapore (1), Mexico (1), Perto Rico (1) and Argentina (1).
#2 14 used a gastrostomy tube, 2 used a nasogastric tube
#3 25 used a gastrostomy tube, 2 used a nasogastric tube
#4 Among children who intook food orally with or without combination use of external nutrition
#5 Excludes child aged younger than 1.5 years
Over 60% (61.8%) of those aged 1.5 years or more were able to sit on the floor without any assistance, whereas only 21.3% were able to walk independently. Less than one fifth (19.6%) were able to communicate using sign or spoken language and approximately a half (53.8%) avoided eye contact. Almost two thirds (64.1%) currently had epileptic seizures on a daily basis. Almost one sixth (15.8%) of the children were dependent on enteral nutrition and the majority (25 of 27) of this group had a gastrostomy. More than half (52.5%) of mothers of those whose children were orally fed, including combination use with enteral feeding, were concerned about the amount of food and/or liquid their child consumed. Almost three quarters (73.2%) of the families had utilised a form of respite care services and with nearly a third (32.7%) receiving both the informal and public services. Nearly half (43.5%) had experienced financial hardship to meet their child’s healthcare needs.

Primary caregiver wellbeing

The mean PCS score was 53.7 (SD 8.6) ranging from 28.0 to 72.7. The univariate analysis identified that the child’s country of birth had the greatest variability in the scores such that mothers of children who were born in Australia and New Zealand, and Western European countries had lower scores than those of children who were born in North America (coefficients = −10.98 and −9.21; p <0.001 and p <0.001, respectively) (Table 2). Those whose child was dependent on enteral nutrition had considerably poorer physical health (mean PCS score 49.6) compared with those whose child fed orally (mean PCS score 54.3; coefficient = −4.72; p = 0.013), as had part-time workers (mean PCS score 50.4) compared with full-time homemakers (mean PCS score 55.1; coefficient = −4.69; p = 0.006). The negative effect of enteral feeding remained significant in the multivariate analysis (coefficient = −4.51; p = 0.015) (Table 3). There was slight improvement in primary caregiver’s physical health for those who used both forms of respite care (coefficient = 1.00; p = 0.603).
Table 2
Univariate analysis for PCS and MCS of the SF-12v2 (n = 158)
Measure
Number of observations
PCS
MCS
Mean (SD) 53.7 (8.6)
Co-efficient
Mean (SD) 41.9 (11.6)
Co-efficient
Parent’s age
152
    
 Under 30 years
12
53.5 (5.9)
Reference
35.9 (15.7)
Reference
 30 to 40 years
80
54.7 (8.7)
1.23
41.9 (11.3)
5.97
 40 years or over
60
52.9 (8.7)
−0.59
43.3 (11.3)
7.37**
Parent’s qualification
147
    
 11 or 12 years of school
27
53.2 (7.9)
Reference
41.8 (13.2)
Reference
 TAFE/Technical certificate
29
53.6 (9.3)
0.40
41.2 (9.0)
−0.57
 University degree
91
54.4 (8.4)
1.14
42.0 (12.1)
−0.23
Maternal work status
147
    
 Full-time homemaker
64
55.1 (8.1)
Reference
42.7 (11.3)
Reference
 Part-time employment
37
50.4 (9.4)
−4.69**
42.4 (11.9)
−0.32
 Full-time employment
46
55.7 (7.5)
0.57
40.8 (11.2)
−1.86
Number of siblings
156
    
 0
36
54.3 (8.1)
Reference
37.4 (13.8)
Reference
 1
64
54.4 (7.5)
0.07
41.9 (11.3)
4.47*
 2 or more
56
52.9 (9.9)
−1.41
45.0 (9.6)
7.56**
Child order
156
    
 The first child
72
54.4 (7.9)
Reference
40.2 (11.7)
Reference
 Laterborn
84
53.3 (9.1)
−1.02
43.5 (11.4)
3.24*
Child’s age
158
    
 Under 1.5 years
24
53.3 (10.0)
Reference
39.8 (13.2)
Reference
 1.5 to 7 years
69
54.6 (7.6)
1.31
42.4 (12.4)
2.63
 7 to 13 years
40
52.7 (9.8)
−0.63
43.7 (9.7)
3.94
 13 years or over
25
53.0 (8.0)
−0.29
39.2 (10.7)
−0.55
Child’s gender
158
    
 Female
136
53.9 (8.3)
Reference
41.8 (11.6)
Reference
 Male
22
52.3 (10.4)
−1.60
41.9 (12.1)
0.10
Child’s country of birth
158
    
 North America
90
56.9 (5.9)
Reference
41.5 (12.1)
Reference
 The United Kingdom
12
54.2 (10.9)
−2.63
41.1 (8.4)
−0.40
 Australia and New Zealand
14
45.9 (7.4)
−10.98**
43.6 (12.5)
2.07
 Western Europe
29
47.6 (10.0)
−9.21**
41.2 (12.2)
−0.30
 Others
13
52.9 (8.2)
−3.93*
44.5 (9.7)
3.02
Mutation group
158
    
 No functional protein
50
53.5 (8.0)
Reference
43.0 (12.0)
Reference
 Missense/In-frame mutations
41
52.5 (9.9)
−0.97
39.5 (10.8)
−3.49
 Truncations aa172 to aa781
44
53.7 (8.7)
0.23
42.0 (11.5)
−0.98
 Truncations after aa781
12
53.6 (7.4)
0.15
46.2 (9.1)
3.21
 Mutations not grouped
11
58.5 (6.5)
5.05*
39.5 (15.1)
−3.49
Feeding pattern
153
    
 Oral intake only
114
54.3 (8.1)
Reference
41.0 (12.2)
Reference
 Combination use
14
55.0 (6.8)
0.74
39.7 (9.4)
−1.32
 Enteral nutrition only
25
49.6 (11.0)
−4.72**
47.4 (9.3)
6.37**
Dietary concerns
123
    
 None
62
55.9 (7.3)
Reference
41.9 (11.7)
Reference
 Occasional
39
51.8 (7.4)
−4.14**
39.9 (12.6)
−2.00
 Frequent or constant
22
55.7 (8.0)
−0.25
42.5 (10.3)
0.67
Floor sitting
129
    
 No assistance
83
54.3 (7.6)
Reference
41.7 (11.7)
Reference
 Some assistance
13
54.5 (7.8)
0.20
42.0 (12.5)
0.27
 Maximal assistance/unable
33
51.3 (10.3)
−3.02*
43.9 (10.6)
2.25
Taking 10 steps forward
126
    
 No assistance
28
54.8 (7.2)
Reference
41.6 (12.6)
Reference
 Some assistance
19
57.3 (7.2)
2.52
40.6 (14.3)
−0.95
 Maximal assistance/unable
79
52.4 (8.9)
−2.37
43.2 (10.4)
1.63
Eye contact
148
    
 No
78
53.0 (9.6)
Reference
41.0 (12.0)
Reference
 Yes
70
54.6 (7.3)
1.57
42.5 (11.7)
1.54
Communication
129
    
 No/Simple method
44
53.0 (9.0)
Reference
44.1 (9.6)
Reference
 Complex gestures/vocalisation
58
53.5 (8.5)
0.52
41.2 (12.4)
−2.91
 Sign/Spoken language
27
55.0 (7.5)
1.98
42.1 (12.0)
−2.02
Seizure frequency
146
    
 Absent
12
53.7 (7.5)
Reference
43.2 (11.3)
Reference
 Yearly/Monthly
15
53.4 (9.8)
−0.33
41.3 (13.1)
−1.82
 Weekly
26
54.5 (6.7)
0.84
40.5 (10.7)
−2.71
 1 to 5 times a day
69
53.4 (8.9)
−0.28
41.1 (12.7)
−2.09
 At least 5 times a day
24
54.2 (9.8)
0.49
45.6 (8.5)
2.47
Sleep difficulties
144
    
 1.00 to 1.50 (1st quartile)
36
54.5 (8.3)
Reference
45.2 (11.3)
Reference
 1.50 to 1.81 (2nd quartile)
38
54.1 (7.7)
−0.46
42.7 (10.8)
−2.58
 1.81 to 2.17 (3rd quartile)
35
54.6 (7.5)
0.11
42.6 (11.2)
−2.63
 2.17 to 5.00 (4th quartile)
35
52.5 (10.1)
−2.00
38.2 (12.1)
−7.06**
Hospitalisation rate
146
    
 0 to 0.38 (1st quartile)
34
52.9 (7.8)
Reference
42.5 (10.2)
Reference
 0.38 to 0.86 (2nd quartile)
38
54.6 (8.3)
1.66
43.0 (12.2)
0.50
 0.86 to 2.14 (3rd quartile)
36
53.1 (8.4)
0.23
39.9 (10.3)
−2.60
 2.14 to 13.70 (4th quartile)
38
54.0 (9.7)
1.11
43.7 (12.2)
1.19
Respite care
148
    
 None
36
54.4 (8.3)
Reference
42.7 (11.8)
Reference
 Formal only
21
52.0 (10.1)
−2.41
44.9 (8.3)
2.21
 Informal only
41
54.1 (8.6)
−0.26
41.1 (13.9)
−1.56
 Both formal and informal
50
53.2 (8.4)
−1.25
40.8 (10.4)
−1.85
Financial difficulty
144
    
 No
83
53.9 (8.5)
Reference
44.0 (11.2)
Reference
 Yes
61
52.9 (8.9)
−0.97
39.1 (11.6)
−4.89**
*p <0.10 **p <0.05
Table 3
Multivariate analysis for PCS and MCS of the SF-12v2 and coefficients#1
Measure
 
PCS
MCS
 
Coefficient (95% CI)
Coefficient (95% CI)
Feeding pattern
Oral intake only
Reference
Reference
Combination use
−1.01 (−5.63, 3.60)
−1.49 (−8.36, 5.37)
Enteral nutrition only
−4.51** (−8.12, −0.89)
6.67** (1.29 to 12.05)
Dietary concerns
None
Reference
Reference
Occasional
−4.98** (−8.11, −1.86)
−0.88 (−5.97, 4.20)
Frequent or constant
−1.81 (−5.51, 1.88)
0.30 (−5.72, 6.32)
Floor sitting
No assistance
Reference
Reference
Some assistance
0.21 (−4.01, 4.42)
−1.59 (−8.14, 4.96)
Maximal assistance/unable
−2.27 (−5.44, 0.90)
1.03 (−3.89, 5.96)
Taking 10 steps forward
No assistance
Reference
Reference
Some assistance
1.20 (−3.52, 5.91)
−1.23 (−8.59, 6.14)
Maximal assistance/unable
−1.85 (−5.34, 1.64)
0.15 (−5.30, 5.61)
Eye contact
No
Reference
Reference
Yes
1.04 (−1.67, 3.75)
1.77 (−2.46, 6.00)
Communication
No/Simple method
Reference
Reference
Complex gestures/vocalisation
0.45 (−2.58, 3.48)
−0.85 (−5.42, 3.72)
Sign/Spoken language
1.03 (−3.00, 5.06)
0.14 (−5.93, 6.21)
Seizure frequency
Absent
Reference
Reference
Yearly/Monthly
−0.55 (−6.78, 5.68)
−2.82 (−12.11, 6.46)
Weekly
0.42 (−5.41, 6.25)
−3.42 (−12.11, 5.27)
1 to 5 times a day
−0.76 (−5.88, 4.35)
−1.90 (−9.52, 5.73)
At least 5 times a day
−0.17 (−6.07, 5.72)
0.09 (−8.69, 8.88)
Sleep difficulties
1.00 to 1.50 (1st quartile)
Reference
Reference
1.50 to 1.81 (2nd quartile)
0.37 (−3.31, 4.04)
−2.58 (−8.11, 2.95)
1.81 to 2.17 (3rd quartile)
2.12 (−1.65, 5.89)
−2.57 (−8.25, 3.10)
2.17 to 5.00 (4th quartile)
1.02 (−2.88, 4.93)
−8.04** (−13.91, −2.16)
Hospitalisation rate
0 to 0.38 (1st quartile)
Reference
Reference
0.38 to 0.86 (2nd quartile)
−0.60 (−4.49, 3.30)
−1.13 (−7.01, 4.73)
0.86 to 2.14 (3rd quartile)
−2.27 (−6.42, 1.87)
−4.22 (−10.47, 2.03)
2.14 to 13.70 (4th quartile)
−1.15 (−5.31, 3.00)
−0.88 (−7.15, 5.38)
Respite care
None
Reference
Reference
Formal only
0.08 (−4.63, 4.79)
1.54 (−5.63, 8.69)
Informal only
−0.80 (−4.57, 2.97)
−1.54 (−7.26, 4.18)
Both formal and informal
1.00 (−2.79, 4.78)
−2.73 (−8.48, 3.02)
Financial difficulty
No
Reference
Reference
Yes
−1.76 (−4.43, 0.92)
−4.75** (−8.78, −0.71)
#1Adjusted for parent’s age (a continuous variable), parent’s qualification (a binary variable; university degree or lower), parent’s work status, number of siblings, the first child, child’s age (a continuous variable) and child’s country of birth (a binary variable; North America or others)
**p <0.05
The mean MCS score was 41.9 (SD 11.6) ranging from 9.3 to 63.2. The number of children in the family, followed by the parent’s age, had the two greatest impacts in the univariate regression analysis (Table 2). Mothers with an only child having the disorder reported the poorest mental wellbeing with a mean of 37.4, compared with having two, and three or more children (coefficient = −4.47 and −7.56; p = 0.061 and 0.002, respectively). MCS scores rose with increasing parent’s age, with the mean score of 41.9 for those aged 30 to 40 years and 43.3 for those aged 40 years or more, compared with that of 35.9 in those aged younger than 30 years (p = 0.101 and 0.048, respectively). Child factors also impacted greatly on the MCS scores. Severity of the child’s sleep disturbances associated negatively with a mean of 38.2 in the highest quartile (i.e. the greatest difficulty) to 45.2 for the lowest (i.e. the least difficulty) (p = 0.010). Mothers of children who were totally dependent on enteral nutrition had the highest MCS with a mean of 47.4, significantly higher than those whose children were totally orally fed (p = 0.013). Experiencing financial hardship adversely affected mental health (coefficient = −4.89; p = 0.011). The multivariate analysis identified that the child’s sleep disturbances had the largest negative effect on MCS scores (coefficient = −8.04; p = 0.008, the highest vs. lowest quartile) (Table 3). The impact of the child’s feeding pattern and financial difficulty experiences remained considerable. Utilisation of respite care services did not appear to be associated with improvement in primary caregiver’s emotional health.
The mean PCS score of 141 of biological mothers was higher overall at 54.0 (SD 8.5), compared with 48.5 (SD 9.9) for the US female norms (p <0.001), but for those aged 25 to 34 years the increase was minimal at 1.4 points (95%CI −1.29, 4.13). On the other hand, the mean MCS score for CDKL5 mothers at 41.5 (SD 11.5), was 6.90 points (95%CI −8.57, −5.23) lower that of the US female norms (p <0.001). The difference was virtually consistent across the age groups.

Family quality of life

Family quality of life was generally rated as satisfactory with an overall score of 4.06 (SD 0.66). Among the subscales, emotional wellbeing scores were lowest with a mean of 3.50 (SD 0.97) and physical/material wellbeing score were the highest with a mean of 4.32 (SD 0.70) (Table 4). The univariate analysis demonstrated that the child’s country of birth profoundly influenced the BCFQOL scores, in which those from Western Europe except the UK had the poorest family quality of life across subscales. Use of respite services was associated adversely with every subscale, with lower BCFQOL scores in family interaction, parenting, emotional wellbeing, physical/material wellbeing and disability-related support observed for those who had received both forms of the services compared to non-users (coefficient = −0.50, −0.35, −0.24, −0.34 and −0.44; p = 0.001, 0.028, 0.268, 0.027 and 0.011, respectively). There was a negative correlation with the SDSC scores such that the families of the children with the greatest sleep difficulties had the lowest scores with all BCFQOL subscales, with the coefficients of −0.34 for family interaction, −0.34 for parenting, −0.57 for emotional wellbeing, −0.41 for physical/material wellbeing and −0.39 for disability-related support compared to the least sleep disturbances (p = 0.054, 0.057, 0.020, 0.015 and 0.040, respectively). Mothers aged 40 years or more reported considerably poorer quality of disability-related support, family interaction and parenting, compared with those aged under 30 years (coefficients = −0.71, −0.45 and −0.34; p = 0.005, 0.056 and 0.159, respectively). The multivariate model identified that those with the most extensive utilisation of respite care had the poorest family quality of life with emotional wellbeing subscale scores being the lowest for those who used formal respite care in comparison with those who had never received such services (Table 5). Particularly, the effects on family interaction, emotional wellbeing, physical/material wellbeing and disability-related support were considerable (coefficients = −0.39, −0.36, −0.32 and −0.39; p = 0.027, 0.127, 0.048 and 0.044, respectively). The impact of child’s sleep difficulty was attenuated after adjusting for PCS and MCS scores.
Table 4
Univariate analysis for the BCFQOL Scale and coefficients (n = 149)
Measure
Number of observations
Family interaction
Parenting
Emotional wellbeing
Physical/Material wellbeing
Disability-related support
 
Mean (SD) 4.22 (0.71)
Mean (SD) 4.15 (0.72)
Mean (SD) 3.50 (0.97)
Mean (SD) 4.32 (0.70)
Mean (SD) 4.13 (0.77)
Parent’s age
143
     
 Under 30 years
11
Reference
Reference
Reference
Reference
Reference
 30 to 40 years
75
−0.18
−0.13
0.07
0.07
−0.51**
 40 years or over
57
−0.45*
−0.34
0.06
−0.06
−0.71**
Parent’s qualification
137
     
 11 or 12 years of school
24
Reference
Reference
Reference
Reference
Reference
 TAFE/Technical certificate
28
0.18
0.10
0.05
0.36*
−0.11
 University degree
85
0.13
0.07
0.07
0.28*
−0.11
Parent’s work status
138
     
 Full-time homemaker
58
Reference
Reference
Reference
Reference
Reference
 Part-time employment
34
−0.21
−0.32**
0.18
−0.19
−0.24
 Full-time employment
46
0.03
−0.06
0.29
−0.03
−0.24
Number of siblings
147
     
 0
29
Reference
Reference
Reference
Reference
Reference
 1
64
−0.10
0.09
−0.17
0.13
−0.03
 2 or more
54
0.04
0.20
−0.10
0.25
0.11
Child order
147
     
 The first child
63
Reference
Reference
Reference
Reference
Reference
 Laterborn
84
0.00
0.10
0.06
0.17
0.05
Child’s age
149
     
 Under 1.5 years
21
Reference
Reference
Reference
Reference
Reference
 1.5 to 7 years
67
0.06
−0.11
−0.32
−0.11
0.09
 7 to 13 years
38
0.00
−0.12
−0.35
−0.11
0.05
 13 years or over
23
−0.21
−0.34
−0.28
−0.36*
−0.09
Child’s gender
149
     
 Female
128
Reference
Reference
Reference
Reference
Reference
 Male
21
0.13
0.07
0.00
0.01
−0.12
Child’s country of birth
149
     
 North America
87
Reference
Reference
Reference
Reference
Reference
 The United Kingdom
12
−0.02
−0.09
−0.05
−0.20
−0.25
 Australia and New Zealand
13
−0.29
−0.48**
−0.21
−0.45**
−0.19
 Western Europe
26
−0.51**
−0.52**
−0.43*
−0.46**
−0.61**
 Others
11
−0.01
−0.18
−0.30
−0.32
−0.22
Mutation group
149
     
 No functional protein
46
Reference
Reference
Reference
Reference
Reference
 Missense/In-frame mutations
36
0.10
0.03
−0.16
0.01
−0.16
 Truncations aa172 to aa781
45
0.05
−0.06
−0.16
0.02
−0.08
 Truncations after aa781
12
0.07
0.06
0.11
0.16
0.06
 Mutations not grouped
10
−0.01
−0.17
−0.06
−0.13
−0.31
Feeding pattern
144
     
 Oral intake only
107
Reference
Reference
Reference
Reference
Reference
 Combination use
14
−0.13
−0.16
−0.04
−0.34*
−0.10
 Enteral nutrition only
23
0.21
0.15
0.15
−0.02
0.06
Dietary concerns
117
     
 None
57
Reference
Reference
Reference
Reference
Reference
 Occasional
38
−0.22
−0.34**
−0.40*
−0.40**
−0.32**
 Frequent or constant
22
0.18
−0.20
−0.02
−0.14
−0.20
Floor sitting
123
     
 No assistance
77
Reference
Reference
Reference
Reference
Reference
 Some assistance
13
0.07
0.07
0.29
−0.04
0.22
 Maximal assistance/unable
33
0.17
0.19
0.15
0.06
0.15
Taking 10 steps forward
20
     
 No assistance
26
Reference
Reference
Reference
Reference
Reference
 Some assistance
17
0.15
−0.05
−0.03
−0.07
−0.04
 Maximal assistance/unable
77
0.16
0.01
0.06
−0.02
0.01
Eye contact
139
     
 No
71
Reference
Reference
Reference
Reference
Reference
 Yes
68
−0.10
−0.11
−0.19
−0.09
−0.05
Communication
123
     
 No/Simple method
42
Reference
Reference
Reference
Reference
Reference
 Complex gestures/vocalisation
57
−0.16
−0.18
−0.38*
−0.16
−0.24
 Sign/Spoken language
24
0.06
0.10
−0.02
0.19
0.18
Seizure frequency
138
     
 Absent
12
Reference
Reference
Reference
Reference
Reference
 Yearly/Monthly
15
−0.28
−0.15
−0.07
−0.25
0.12
 Weekly
25
−0.29
−0.03
0.14
−0.19
−0.03
 1 to 5 times a day
62
−0.15
−0.00
0.11
−0.09
0.09
 At least 5 times a day
24
−0.11
0.14
0.39
−0.06
0.22
Sleep difficulties
136
     
 1.00 to 1.50 (1st quartile)
34
Reference
Reference
Reference
Reference
Reference
 1.50 to 1.81 (2nd quartile)
37
−0.24
−0.23
−0.42*
−0.33**
−0.37**
 1.81 to 2.17 (3rd quartile)
32
−0.19
−0.20
−0.34
−0.07
−0.14
 2.17 to 5.00 (4th quartile)
33
−0.34*
−0.34*
−0.57**
−0.41**
−0.39**
Hospitalisation rate
139
     
 0 to 0.38 (1st quartile)
31
Reference
Reference
Reference
Reference
Reference
 0.38 to 0.86 (2nd quartile)
36
0.19
0.17
0.13
0.15
0.25
 0.86 to 2.14 (3rd quartile)
35
0.01
−0.09
−0.42
−0.07
0.15
 2.14 to 13.70 (4th quartile)
37
0.20
0.35**
0.06
0.07
0.16
Respite care
140
     
 None
37
Reference
Reference
Reference
Reference
Reference
 Formal only
21
−0.27
−0.18
−0.56**
−0.16
−0.15
 Informal only
35
−0.12
−0.19
−0.37
−0.27*
−0.31*
 Both formal and informal
47
−0.50**
−0.35**
−0.24
−0.34**
−0.44**
Financial difficulty
137
     
 No
76
Reference
Reference
Reference
Reference
Reference
 Yes
61
0.03
−0.09
−0.57**
−0.22*
−0.09
*p < 0.10 **p < 0.05
Table 5
Multivariate analysis for the BCFQOL Scale and coefficients#1
Measure
 
Family interaction
Parenting
Emotional wellbeing
Physical/Material wellbeing
Disability-related support
Feeding pattern
Oral intake only
Reference
Reference
Reference
Reference
Reference
Combination use
−0.12
−0.16
0.13
−0.16
0.13
Enteral nutrition only
0.07
0.02
-0.06
-0.03
-0.06
Dietary concerns
None
Reference
Reference
Reference
Reference
Reference
Occasional
−0.15
−0.25
−0.08
−0.25
−0.19
Frequent or constant
−0.29
−0.29
0.19
−0.19
−0.26
Floor sitting
No assistance
Reference
Reference
Reference
Reference
Reference
Some assistance
−0.02
0.05
0.42
−0.10
0.17
Maximal assistance/Unable
0.17
0.16
0.19
0.14
0.20
Taking 10 steps forward
No assistance
Reference
Reference
Reference
Reference
Reference
Some assistance
0.21
−0.03
0.13
0.02
0.09
Maximal assistance/Unable
0.18
0.08
0.25
0.09
0.07
Eye contact
No
Reference
Reference
Reference
Reference
Reference
Yes
−0.16
−0.18
−0.19
−0.12
−0.05
Communication
No/Simple method
Reference
Reference
Reference
Reference
Reference
Complex gestures/vocalisation
−0.12
−0.11
−0.33*
−0.11
−0.15
Sign/Spoken language
−0.02
−0.02
−0.31
0.03
0.06
Seizure frequency
Absent
Reference
Reference
Reference
Reference
Reference
Yearly/Monthly
−0.28
−0.06
0.40
−0.15
0.26
Weekly
−0.12
0.13
0.57*
−0.05
0.26
1 to 5 times a day
−0.25
−0.06
0.13
−0.06
0.18
At least 5 times a day
−0.07
0.14
0.53
0.06
0.35
Sleep difficulties
1.00 to 1.50 (1st quartile)
Reference
Reference
Reference
Reference
Reference
1.50 to 1.81 (2nd quartile)
−0.10
−0.08
−0.28
−0.09
−0.28
1.81 to 2.17 (3rd quartile)
−0.06
−0.03
−0.26
0.08
−0.10
2.17 to 5.00 (4th quartile)
−0.15
−0.09
−0.26
−0.16
−0.23
Hospitali-sation rate
0 to 0.38 (1st quartile)
Reference
Reference
Reference
Reference
Reference
0.38 to 0.86 (2nd quartile)
0.14
0.07
0.09
−0.01
0.21
0.86 to 2.14 (3rd quartile)
−0.07
−0.18
−0.37
−0.22
0.08
2.14 to 13.70 (4th quartile)
0.10
0.24
0.09
0.03
0.13
Respite care
None
Reference
Reference
Reference
Reference
Reference
Formal only
−0.29
−0.18
−0.72**
−0.07
−0.01
Informal only
−0.06
−0.20
−0.47**
−0.23
−0.28
Both formal and informal
−0.39**
−0.26
−0.36
−0.32**
−0.39**
Financial difficulty
No
Reference
Reference
Reference
Reference
Reference
Yes
0.11
0.04
−0.27
0.03
0.02
#1Adjusted for parent’s age (a continuous variable), parent’s qualification (a binary variable; university degree or lower), parent’s work status, number of siblings, the first child, child’s age (a continuous variable), child’s country of birth (a binary variable; North America or others) and the scores of PCS and MCS (continuous variables)
*p <0.10 **p <0.05

Discussion

Caregivers of children with the CDKL5 disorder experienced considerable emotional burden. Despite better physical wellbeing, emotional wellbeing (MCS 41.9, SD 11.6) was compromised in comparison with the US female norms and was poorer than has been demonstrated in Australian research in both Rett syndrome [12] (MCS 42.4, SD 10.2) and Down syndrome [11] (MCS 45.2, SD 10.6). In contrast, a large proportion of mothers in the international CDKL5 disorder sample were from the US, and generally younger than those in the Australian studies [11, 12], factors which may also have some bearing on the findings.
Emotional wellbeing of primary care givers was particularly poor when the child was an only child, the child’s co-occurring sleep disturbances were severe, and the family had faced financial hardships to meet the child’s healthcare needs. These associations are broadly consistent with findings of most previous research. Poor maternal sleep quality, often a sequela of child’s sleep disturbances, has been shown to be an important predictor of depression in mothers of children with developmental disabilities, mostly autism spectrum disorder [2327] or cerebral palsy [28]. Moreover, a similar relationship to that we identified with financial hardship was demonstrated in a Canadian study involving mothers with a child with a developmental disability [29].
Our study reveals some unique findings. Firstly, mental health was least impaired in mothers caring for a child who was totally tube fed, whereas this was the group with the poorest physical health. The literature has shown variability in parent’s experiences for those with a child with a disability after the child’s gastrostomy placement, although enhancement in nutritional status has been reported [3033]. Parents have reported less burden of care at mealtimes, reduced stress that their child is inadequately nourished, and relief that medications are consistently delivered, consequently improving their emotional wellbeing [3034]. In a previous study with primary caregivers of a child with Rett syndrome we found that there was general satisfaction with outcomes following gastrostomy insertion [30]. This was related to improved well-being and nutritional status of the child and for the parent reduced care demands and less concern about feeding and the delivery of medication [30]. In this study of the CDKL5 disorder, it is likely that some children may have had the gastrostomy placement in order to facilitate the provision of a ketogenic diet [35], which might have helped control seizures and in turn ease emotional burden of care for the parents. Although primary caregiver’s physical health was not adversely affected by gastrostomy placement in those with a child with cerebral palsy [36], increased demands or excessive weight gain of the child could be contributing to mothers’ physical burden in our study. Thus some deterioration in caregiver physical health may accompany better emotional health, which has been a consequence of less mealtime stress and improved child well-being.
Secondly, while a slight improvement in physical wellbeing was demonstrated, respite care use did not have a positive impact on the mental health of the primary caregivers. Furthermore, families who had utilised these services were less satisfied with every aspect of their family quality of life compared with non-users. Despite contrasting findings from a systematic review [37], individual studies have shown that service utilisation either had no positive effect [29] or was negatively associated with carer’s emotional health [38, 39]. Our longitudinal study involving families with a child with Rett syndrome found that respite care use did not improve parental emotional health and was associated with worse physical health over two years of follow-up [40]. Furthermore, in other research increased family needs for support have been reported to be associated with poorer family quality of life [41]. Our findings might suggest that needs for respite care are not being met for some families and that the current framework for service delivery is not enhancing parental wellbeing or family quality of life. However, this issue warrants further investigation, possibly using either a longitudinal study design and/or qualitiative methods.
Thirdly, mothers in the youngest age group experienced the most impaired emotional health, possibly related to the recency of receiving their child’s diagnosis, a time when they could be experiencing overwhelming fear and loneliness [42]. However, establishing a diagnosis is imperative so that families can clarify their child’s expected life course and gain disease-specific family support [43]. Parents of a child with intellectual disability reported their wellbeing as better when the child had received a definite diagnosis [17]. As the CDKL5 gene testing has become available over the last decade, some of older primary caregivers in this study might have felt greatly relieved when their adult child eventually received a clear diagnosis. That said even in the general population mental health scores do improve with age [20], but for those with a CDKL5-affected child, we showed that the mean MCS score was consistently poorer across all age groups.
Lastly, family quality of life was strongly mediated by primary caregiver’s health status. The mother’s report of family quality of life has been assessed in most studies [16], and mothers under stress are more likely to consider their family quality of life as poorer [15]. In our study, adjustment for the SF-12v2 scores indicated that child’s sleep difficulty had less impact on the whole family than on the primary carer. Controlling for maternal health would be of use to verify pathways from potential predictors to family quality of life.
We were surprised that there were no strong associations between the frequency of seizures or the attainment of gross motor and communication skills and family outcomes, given the major burden of epilepsy and the severe physical and intellectual impairment in the CDKL5 disorder. Previous studies on the effect of seizure control on maternal mental health have had mixed findings although mostly undertaken in children who were otherwise healthy [4448]. The marked intellectual disability and various comorbidities among children with the CDKL5 disorder may lessen the influence of seizures alone on the primary caregiver’s health.
Finally, we did not find any association between the rate of hospitalisations and primary caregiver health or family quality of life. In our study, all hospitalisations experienced by the child with the CDKL5 disorder over the life course were included, whereas the outcomes related to current status. We therefore may not be able to observe any true relationships.
Our study has several limitations. First, we used a cross-sectional study design and because of the absence of longitudinal data we were restricted to the reporting of associations rather than causal relationships. Secondly, despite the growth of our international database, the ICDD is not a population-based study. Hence, while remarkable heterogeneity in the carer’s physical health and family quality of life were found according to child’s country of birth, it might be explained by the uneven distribution of participants as well as voluntary participation. Thirdly, we did not account for the child’s age when a diagnosis was made. Time intervals from when parents first had concerns about their child to the age at diagnosis and from the age at diagnosis to the present might influence the primary caregiver’s emotional wellbeing. Fourthly, family quality of life was reported solely by the primary caregiver although adjustment for the SF-12v2 scores would have helped to counteract any confounding effect.

Conclusions

Despite its shortcomings, we believe that this study provides important insights into primary caregiver’s wellbeing and family quality of life among families with a child with a severe genetic disorder, previously difficult to study because of its rarity. Child’s feeding methods and sleep difficulties, and experiences of financial hardship were associated with primary caregiver’s wellbeing, whereas use of respite care services was the principal correlate with family quality of life after controlling for the carer’s health among families with a child with the CDKL5 disorder included in this study. To date, minimal attention has been given to families with a child living with a rare genetic disorder. Although we still acknowledge the need for further longitudinal investigation, the current research has only been possible for the CDKL5 disorder through the implementation and development of a worldwide database.

Acknowledgements

We would like to express our deep gratitude to all the families who have participated in the International CDKL5 disorder Database. We would also like to thank the International Foundation for CDKL5 Research for funding and ongoing support. We acknowledge the work of Dr. Stephanie Fehr and the Western Sydney Genetics Program at the Children’s Hospital at Westmead, Sydney for interpretation of genetic reports.

Funding

This study as well as management of the International CDKL5 Disorder Database was supported by the International Foundation for CDKL5 Research.

Availability of data and materials

The datasets analysed during the current study are not publicly available but may be available from the corresponding author on reasonable request following an application to and with approval from the local ethics committee.

Authors’ contribution

This study was conceptualised by HL and JD both of whom participated in the organisation and execution of the study including drafting and reviewing of the manuscript. YM participated with HL and JD in the study design and organisation. YM and KW designed and executed the statistical analysis. All authors contributed to the drafting and critique of the manuscript and read and approved the final manuscript.

Competing interests

On behalf of all authors, the corresponding author states that there is no conflict of interest.
Not applicable.
Ethical approval for the study was obtained from the Ethics Committee of the University of Western Australia. Consent was obtained from all participants after information on the International CDKL5 Disorder Database was fully provided by the staff member.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Weaving L, Christodoulou J, Williamson S, Friend K, McKenzie O, Archer H, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75:1079–93.CrossRefPubMedPubMedCentral Weaving L, Christodoulou J, Williamson S, Friend K, McKenzie O, Archer H, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75:1079–93.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Kalsheuer V, Tao J, Donnelly A, Hollway G, Schwinger E, Kubart S, et al. Disruption of the serine/threonine kinase 9 gene causes Dever X-linked infantile spasms and mental retardation. Am J Hum Genet. 2003;72:1401–11.CrossRef Kalsheuer V, Tao J, Donnelly A, Hollway G, Schwinger E, Kubart S, et al. Disruption of the serine/threonine kinase 9 gene causes Dever X-linked infantile spasms and mental retardation. Am J Hum Genet. 2003;72:1401–11.CrossRef
3.
Zurück zum Zitat Evans J, Archer H, Colley J, Ravn K, Nielsen J, Kerr A, et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet. 2005;13:1113–20.CrossRefPubMed Evans J, Archer H, Colley J, Ravn K, Nielsen J, Kerr A, et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet. 2005;13:1113–20.CrossRefPubMed
4.
Zurück zum Zitat Fehr S, Wilson M, Downs J, Williams S, Murgia A, Sartori S, et al. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur J Hum Genet. 2013;21:266–73. Fehr S, Wilson M, Downs J, Williams S, Murgia A, Sartori S, et al. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur J Hum Genet. 2013;21:266–73.
5.
Zurück zum Zitat Guerrini R, Parrini E. Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies. Epilepsia. 2012;53(12):2067–78.CrossRefPubMed Guerrini R, Parrini E. Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies. Epilepsia. 2012;53(12):2067–78.CrossRefPubMed
6.
Zurück zum Zitat Mangatt M, Wong K, Anderson B, Epstein A, Hodgetts S, Leonard H, et al. Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome. Orphanet J Rare Dis. 2016;11:39. Mangatt M, Wong K, Anderson B, Epstein A, Hodgetts S, Leonard H, et al. Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome. Orphanet J Rare Dis. 2016;11:39.
7.
Zurück zum Zitat Fehr S, Wong K, Chin R, Williams S, de Klerk N, Forbes D, et al. Seizure variabiles and their relationship to genotype and functional abilities in the CDKL5 disorder. Neurology. 2016;87:2206–13.CrossRefPubMed Fehr S, Wong K, Chin R, Williams S, de Klerk N, Forbes D, et al. Seizure variabiles and their relationship to genotype and functional abilities in the CDKL5 disorder. Neurology. 2016;87:2206–13.CrossRefPubMed
8.
Zurück zum Zitat Fehr S, Leonard H, Ho G, Williams S, Klerk N, Forbes D, et al. There is variability in the attainment of developmental milestones in the CDKL5 disorder. J Neurodev Disord. 2015;7:2.CrossRefPubMedPubMedCentral Fehr S, Leonard H, Ho G, Williams S, Klerk N, Forbes D, et al. There is variability in the attainment of developmental milestones in the CDKL5 disorder. J Neurodev Disord. 2015;7:2.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Totsika V, Hastings R, Emerson E, Lancaster G, Berridge D. A population-based investigation of behavioural and emotional problems and maternal mental stress: associations with autism spectrum disorder and intellectual disability. J Child Psychol Psychiatry. 2011;52(1):91–9.CrossRefPubMed Totsika V, Hastings R, Emerson E, Lancaster G, Berridge D. A population-based investigation of behavioural and emotional problems and maternal mental stress: associations with autism spectrum disorder and intellectual disability. J Child Psychol Psychiatry. 2011;52(1):91–9.CrossRefPubMed
10.
Zurück zum Zitat Zablotsky B, Bradshaw C, Stuart E. The association between mental health, stress, and coping supports in mothers of children with autism spectrum disorders. J Autism Dev Disord. 2013;43:1380–93.CrossRefPubMed Zablotsky B, Bradshaw C, Stuart E. The association between mental health, stress, and coping supports in mothers of children with autism spectrum disorders. J Autism Dev Disord. 2013;43:1380–93.CrossRefPubMed
11.
Zurück zum Zitat Bourke J, Ricciardo B, Bebbington A, Aiberti K, Jacoby P, Dyke P, et al. Physical and mental health in mothers of children with Down syndrome. J Pediatr. 2008;153:320–6. Bourke J, Ricciardo B, Bebbington A, Aiberti K, Jacoby P, Dyke P, et al. Physical and mental health in mothers of children with Down syndrome. J Pediatr. 2008;153:320–6.
12.
Zurück zum Zitat Laurvick C, Msall M, Silburn S, Bower C, de Klerk N, Leonard H. Physical and mental health of mothers caring for a child with Rett syndrome. Pediatrics. 2006;118:e1152–64.CrossRefPubMed Laurvick C, Msall M, Silburn S, Bower C, de Klerk N, Leonard H. Physical and mental health of mothers caring for a child with Rett syndrome. Pediatrics. 2006;118:e1152–64.CrossRefPubMed
13.
Zurück zum Zitat Cianfaglione R, Hastings R, Felce D, Clarke A, Kerr M. Psychological well-being of mothers and siblings in families of girls and women with Rett syndrome. J Autism Dev Disord. 2015;45:2939–46.CrossRefPubMed Cianfaglione R, Hastings R, Felce D, Clarke A, Kerr M. Psychological well-being of mothers and siblings in families of girls and women with Rett syndrome. J Autism Dev Disord. 2015;45:2939–46.CrossRefPubMed
14.
Zurück zum Zitat Tvrdik T, Mason D, Dent K, Thornton L, Hornton S, Viskochil D, et al. Stress and coping in parents of children with Prader-Willi syndrome: assessment of the impact of a structured plan of care. Am J Med Genet. 2014;167A:974–82. Tvrdik T, Mason D, Dent K, Thornton L, Hornton S, Viskochil D, et al. Stress and coping in parents of children with Prader-Willi syndrome: assessment of the impact of a structured plan of care. Am J Med Genet. 2014;167A:974–82.
15.
Zurück zum Zitat Gardiner E, Iarocci G. Unhappy (and happy) in their own way: a developmental psychopathology perspective on quality of life for families living with developmental disability with and without autism. Res Dev Disabil. 2012;33:2177–92.CrossRefPubMed Gardiner E, Iarocci G. Unhappy (and happy) in their own way: a developmental psychopathology perspective on quality of life for families living with developmental disability with and without autism. Res Dev Disabil. 2012;33:2177–92.CrossRefPubMed
16.
Zurück zum Zitat Zuna N, Brown I, Brown R. Family quality of life in intellectual and developmental disabilities: a support-based framework. Int J Public Health. 2014;6(2):161–84. Zuna N, Brown I, Brown R. Family quality of life in intellectual and developmental disabilities: a support-based framework. Int J Public Health. 2014;6(2):161–84.
17.
Zurück zum Zitat Tibben A. Obtaining a genetic diagnosis in a child with disability: impact on parental quality of life. Clin Genet. 2016;89:258–66.CrossRef Tibben A. Obtaining a genetic diagnosis in a child with disability: impact on parental quality of life. Clin Genet. 2016;89:258–66.CrossRef
18.
Zurück zum Zitat Louise S, Fyfe S, Bebbington A, Bahi-Buisson N, Anderson A, Pineda M, et al. InterRett, a model for international data collection in a rare genetic disorder. Res Autism Spect Dis. 2009;3:639–59.CrossRef Louise S, Fyfe S, Bebbington A, Bahi-Buisson N, Anderson A, Pineda M, et al. InterRett, a model for international data collection in a rare genetic disorder. Res Autism Spect Dis. 2009;3:639–59.CrossRef
19.
Zurück zum Zitat Bruni O, Ottaviano S, Guidetti V, Romoli M, Innocenzi M, Cortesi F, et al. The sleep disturbance scale for children (SDSC) construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res. 1996;5:251–61.CrossRefPubMed Bruni O, Ottaviano S, Guidetti V, Romoli M, Innocenzi M, Cortesi F, et al. The sleep disturbance scale for children (SDSC) construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res. 1996;5:251–61.CrossRefPubMed
20.
Zurück zum Zitat Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Licoln, Rhode Island: QualityMetric Incorporated; 2004. Ware J, Kosinski M, Turner-Bowker D, Gandek B. How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Licoln, Rhode Island: QualityMetric Incorporated; 2004.
21.
Zurück zum Zitat Samuel P, Rillotta F, Brown I. Review: the development of family quality of life concepts and measures. J Intellect Disabil Res. 2012;56(1):1–16.CrossRefPubMed Samuel P, Rillotta F, Brown I. Review: the development of family quality of life concepts and measures. J Intellect Disabil Res. 2012;56(1):1–16.CrossRefPubMed
22.
Zurück zum Zitat Hoffman L, Marquis J, Poston D, Summers J, Turnbull A. Assessing family outcomes: psychometric evaluation of the beach center family quality of life scale. J Marriage Fam. 2006;68:1069–83.CrossRef Hoffman L, Marquis J, Poston D, Summers J, Turnbull A. Assessing family outcomes: psychometric evaluation of the beach center family quality of life scale. J Marriage Fam. 2006;68:1069–83.CrossRef
23.
Zurück zum Zitat Bourke-Taylor H, Pallant J, Law M, Howie L. Predicting mental health among mothers of school-aged children with developmental disabilities: the relative contribution of child, maternal and environmental factors. Res Dev Disabil. 2012;33:1732–40.CrossRefPubMed Bourke-Taylor H, Pallant J, Law M, Howie L. Predicting mental health among mothers of school-aged children with developmental disabilities: the relative contribution of child, maternal and environmental factors. Res Dev Disabil. 2012;33:1732–40.CrossRefPubMed
24.
Zurück zum Zitat Lee J. Maternal stress, well-being, and impaired sleep in mothers of children with developmental disabilities: a liternature review. Res Dev Disabil. 2013;34:4255–73.CrossRefPubMed Lee J. Maternal stress, well-being, and impaired sleep in mothers of children with developmental disabilities: a liternature review. Res Dev Disabil. 2013;34:4255–73.CrossRefPubMed
25.
Zurück zum Zitat Chu J, Richdale A. Sleep quality and psychological wellbeing in mothers of children with developmental disabilities. Res Dev Disabil. 2009;30:1512–22.CrossRefPubMed Chu J, Richdale A. Sleep quality and psychological wellbeing in mothers of children with developmental disabilities. Res Dev Disabil. 2009;30:1512–22.CrossRefPubMed
26.
Zurück zum Zitat Bourke-Taylor H, Pallant J, Law M, Howie L. Relationships between sleep disruptions, health and care responsibilities among mothers of school-aged children with disabilities. J Paediatr Child Health. 2013;49:775–82.CrossRefPubMed Bourke-Taylor H, Pallant J, Law M, Howie L. Relationships between sleep disruptions, health and care responsibilities among mothers of school-aged children with disabilities. J Paediatr Child Health. 2013;49:775–82.CrossRefPubMed
27.
Zurück zum Zitat Hodge D, Hoffman C, Sweeney D, Riggs M. Relationship between children’s sleep and mental health in mothers with and without autism. J Autism Dev Disord. 2013;43:956–63.CrossRefPubMed Hodge D, Hoffman C, Sweeney D, Riggs M. Relationship between children’s sleep and mental health in mothers with and without autism. J Autism Dev Disord. 2013;43:956–63.CrossRefPubMed
28.
Zurück zum Zitat Wayte S, McCaughey E, Holley S, Annaz D, Hill C. Sleep problems in children with cerebral palsy and their relationship with maternal sleep and depression. Acta Paediatr. 2012;101:618–23.CrossRefPubMed Wayte S, McCaughey E, Holley S, Annaz D, Hill C. Sleep problems in children with cerebral palsy and their relationship with maternal sleep and depression. Acta Paediatr. 2012;101:618–23.CrossRefPubMed
29.
Zurück zum Zitat Minnes P, Perry A, Weiss J. Predictors of distress and well-being in parents of young children with developmental delays and disabilities: the importance of parent perceptions. J Intellect Disabil Res. 2015;59(6):551–60.CrossRefPubMed Minnes P, Perry A, Weiss J. Predictors of distress and well-being in parents of young children with developmental delays and disabilities: the importance of parent perceptions. J Intellect Disabil Res. 2015;59(6):551–60.CrossRefPubMed
30.
Zurück zum Zitat Downs J, Wong K, Ravikumara M, Ellaway C, Elliot E, Christodoulou J, et al. Experience of gastrostomy using a quality care framework: the example of Rett syndrome. Medicine. 2014;93(28):e328.CrossRefPubMedPubMedCentral Downs J, Wong K, Ravikumara M, Ellaway C, Elliot E, Christodoulou J, et al. Experience of gastrostomy using a quality care framework: the example of Rett syndrome. Medicine. 2014;93(28):e328.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Wilken M. The impact of child tube feeding on maternal emotional state and identity: a qualitative meta-analysis. J Pediatr Nurs. 2012;27:248–55.CrossRefPubMed Wilken M. The impact of child tube feeding on maternal emotional state and identity: a qualitative meta-analysis. J Pediatr Nurs. 2012;27:248–55.CrossRefPubMed
32.
Zurück zum Zitat Brotherton A, Abbott J, Aggett P. The impact of percutaneous endoscopic gastrostomy feeding in children; the parental perspective. Child Care Health Dev. 2007;33(5):539–46.CrossRefPubMed Brotherton A, Abbott J, Aggett P. The impact of percutaneous endoscopic gastrostomy feeding in children; the parental perspective. Child Care Health Dev. 2007;33(5):539–46.CrossRefPubMed
33.
Zurück zum Zitat Mahant S, Jovcevska V, Cohen E. Decision-making around gastrostomy-feeding in children with neurologic disabilities. Pediatrics. 2011;127:e1471.CrossRefPubMed Mahant S, Jovcevska V, Cohen E. Decision-making around gastrostomy-feeding in children with neurologic disabilities. Pediatrics. 2011;127:e1471.CrossRefPubMed
34.
Zurück zum Zitat Nelson K, Lacombe-Duncan A, Cohen E, Nicholas D, Rosella L, Guttmann A, et al. Family experiences with feeding tubes in neurologic impairment: a systematic review. Pediatrics. 2015;136:e140–51.CrossRefPubMed Nelson K, Lacombe-Duncan A, Cohen E, Nicholas D, Rosella L, Guttmann A, et al. Family experiences with feeding tubes in neurologic impairment: a systematic review. Pediatrics. 2015;136:e140–51.CrossRefPubMed
35.
Zurück zum Zitat Muller A, Helbig I, Jansen C, Bast T, Guerrini R, Jahn J, et al. Retrospectie evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy. Eur J Paediatr Neurol. 2016;20:147–51.CrossRefPubMed Muller A, Helbig I, Jansen C, Bast T, Guerrini R, Jahn J, et al. Retrospectie evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy. Eur J Paediatr Neurol. 2016;20:147–51.CrossRefPubMed
36.
Zurück zum Zitat Sullivan P, Juszczak E, Bachlet A, Lambert B, Vernon-Roberts A, Grant H, et al. Impact of gastrostomy tube feeding on the quality of life of cares of children with cerebral palsy. Dev Med Child Neurol. 2004;46:796–800.CrossRefPubMed Sullivan P, Juszczak E, Bachlet A, Lambert B, Vernon-Roberts A, Grant H, et al. Impact of gastrostomy tube feeding on the quality of life of cares of children with cerebral palsy. Dev Med Child Neurol. 2004;46:796–800.CrossRefPubMed
37.
Zurück zum Zitat Strunk J. Respite care for families of special needs children: a systematic review. J Dev Phys Disabil. 2010;22:615–30.CrossRef Strunk J. Respite care for families of special needs children: a systematic review. J Dev Phys Disabil. 2010;22:615–30.CrossRef
38.
Zurück zum Zitat Sawyer M, Bittman M, Greca A, Crettenden A, Harchak T, Martin J. Time demands of caring for children with autism: what are the implications for maternal mental health? J Autism Dev Disord. 2010;40:620–8.CrossRefPubMed Sawyer M, Bittman M, Greca A, Crettenden A, Harchak T, Martin J. Time demands of caring for children with autism: what are the implications for maternal mental health? J Autism Dev Disord. 2010;40:620–8.CrossRefPubMed
39.
Zurück zum Zitat Carter A, Martinez-Pedraza F, Gray S. Stability and individual change in depressive symptoms among mothers raising young children with ASD: maternal and child correlates. J Clin Psychol. 2009;65(12):1270–80.CrossRefPubMed Carter A, Martinez-Pedraza F, Gray S. Stability and individual change in depressive symptoms among mothers raising young children with ASD: maternal and child correlates. J Clin Psychol. 2009;65(12):1270–80.CrossRefPubMed
40.
Zurück zum Zitat Urbanowicz A, Downs J, Bebbington A, Jacoby P, Girder S, Leonard H. Use of equipment and respite services and caregiver health among Australian families living with Rett syndrome. Res Autism Spectr Disord. 2011;5:722–32.CrossRef Urbanowicz A, Downs J, Bebbington A, Jacoby P, Girder S, Leonard H. Use of equipment and respite services and caregiver health among Australian families living with Rett syndrome. Res Autism Spectr Disord. 2011;5:722–32.CrossRef
41.
Zurück zum Zitat Boehm T, Carter E, Taylor J. Family quality of life during the transition to adulthood for individuals with intellectual difficulty and/or autism spectrum disorders. Am J Intellect Dev Disabil. 2015;120(5):395–411.CrossRefPubMed Boehm T, Carter E, Taylor J. Family quality of life during the transition to adulthood for individuals with intellectual difficulty and/or autism spectrum disorders. Am J Intellect Dev Disabil. 2015;120(5):395–411.CrossRefPubMed
42.
Zurück zum Zitat Glenn A. Using online health communication to manage chronic sorrow: mothers of children with rare diseases speak. J Pediatr Nurs. 2015;30:17–24.CrossRefPubMed Glenn A. Using online health communication to manage chronic sorrow: mothers of children with rare diseases speak. J Pediatr Nurs. 2015;30:17–24.CrossRefPubMed
43.
Zurück zum Zitat Moeschler J, Shevell M. Genetics Co. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:e903–18.CrossRefPubMed Moeschler J, Shevell M. Genetics Co. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:e903–18.CrossRefPubMed
44.
Zurück zum Zitat Lv R, Wu L, Jin L, Lu Q, Wang M, Qu Y, et al. Depression, auxiety and quality of life in parents of children with epilepsy. Acta Neurol Scand. 2009;120:335–41.CrossRefPubMed Lv R, Wu L, Jin L, Lu Q, Wang M, Qu Y, et al. Depression, auxiety and quality of life in parents of children with epilepsy. Acta Neurol Scand. 2009;120:335–41.CrossRefPubMed
45.
Zurück zum Zitat Akay A, Kurul S, Ozek H, Cengizhan S, Emiroglu N, Ellidokuz H. Maternal reactions to a child with epilepsy: depression, anxiety, parental attitudes and family functions. Epilepsy Res. 2011;95:213–20.CrossRef Akay A, Kurul S, Ozek H, Cengizhan S, Emiroglu N, Ellidokuz H. Maternal reactions to a child with epilepsy: depression, anxiety, parental attitudes and family functions. Epilepsy Res. 2011;95:213–20.CrossRef
46.
Zurück zum Zitat Young L, Chengye J, Jiong Q. Factors affecting the quality of life in childhood epilepsy in China. Acta Neurol Scand. 2006;113:167–73.CrossRef Young L, Chengye J, Jiong Q. Factors affecting the quality of life in childhood epilepsy in China. Acta Neurol Scand. 2006;113:167–73.CrossRef
47.
Zurück zum Zitat Kerne V, Chapieski L. Adaptive functioning in pediatric epilepsy: contributions of seizure-related variables and parental anxiety. Epilepsy Behav. 2015;43:48–52.CrossRefPubMed Kerne V, Chapieski L. Adaptive functioning in pediatric epilepsy: contributions of seizure-related variables and parental anxiety. Epilepsy Behav. 2015;43:48–52.CrossRefPubMed
48.
Zurück zum Zitat Williams J, Steel C, Sharp G, DelosReyes E, Phillips T, Bates S, et al. Parental anxiety and quality of life in children with epilepsy. Epilepsy Behav. 2003;4:483–6.CrossRefPubMed Williams J, Steel C, Sharp G, DelosReyes E, Phillips T, Bates S, et al. Parental anxiety and quality of life in children with epilepsy. Epilepsy Behav. 2003;4:483–6.CrossRefPubMed
Metadaten
Titel
Impacts of caring for a child with the CDKL5 disorder on parental wellbeing and family quality of life
verfasst von
Yuka Mori
Jenny Downs
Kingsley Wong
Barbara Anderson
Amy Epstein
Helen Leonard
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Orphanet Journal of Rare Diseases / Ausgabe 1/2017
Elektronische ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-016-0563-3

Weitere Artikel der Ausgabe 1/2017

Orphanet Journal of Rare Diseases 1/2017 Zur Ausgabe